Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Cow (Bovine) Polyclonal PDE4B Primary Antibody for WB - ABIN2786603
Fatemi, King, Reutiman, Folsom, Laurence, Lee, Fan, Paciga, Conti, Menniti: PDE4B polymorphisms and decreased PDE4B expression are associated with schizophrenia. in Schizophrenia research 2008
Show all 2 Pubmed References
Human Polyclonal PDE4B Primary Antibody for ICC, IF - ABIN4344430
Cedervall, Aulabaugh, Geoghegan, McLellan, Pandit: Engineered stabilization and structural analysis of the autoinhibited conformation of PDE4. in Proceedings of the National Academy of Sciences of the United States of America 2015
Human Polyclonal PDE4B Primary Antibody for CM, ICC - ABIN2750909
Massimi, Cardarelli, Galli, Giardi, Ragusa, Panera, Cinque, Cifone, Biagioni, Giorgi: Increase of Intracellular Cyclic AMP by PDE4 Inhibitors Affects HepG2 Cell Cycle Progression and Survival. in Journal of cellular biochemistry 2016
Human Polyclonal PDE4B Primary Antibody for IP, ELISA - ABIN2750915
Vang, Housley, Dong, Basole, Ben-Sasson, Kream, Epstein, Clark, Brocke: Regulatory T-cells and cAMP suppress effector T-cells independently of PKA-CREM/ICER: a potential role for Epac. in The Biochemical journal 2013
Mouse (Murine) Polyclonal PDE4B Primary Antibody for ELISA, WB - ABIN250999
Millar, Pickard, Mackie, James, Christie, Buchanan, Malloy, Chubb, Huston, Baillie, Thomson, Hill, Brandon, Rain, Camargo, Whiting, Houslay, Blackwood, Muir, Porteous: DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. in Science (New York, N.Y.) 2005
PDE4B1-D564A transgenic mice demonstrate increased phosphorylation of CREB and ERK1/2, consistent with activation of PKA, ERK1/2 and potentially other kinases, increased hippocampal neurogenesis, and alterations in hippocampal slice electrophysiology consistent with augmentation of hippocampal long-term potentiation. Mice are more active but have no major changes in associative learning or other behavior.
Pharmacologic and gene knock-out results suggest that Pde4b plays a critical role in coordinating alcohol-induced, peripheral endotoxemia mediated neuro-inflammation and could serve as a significant therapeutic target.
These results demonstrate that the alcohol- induced increase in hepatic Pde4 (show PDE4A Antibodies), specifically Pde4b expression, and compromised cAMP signalling predispose the liver to impaired fatty acid oxidation and the development of steatosis.
PDE4B phosphorylated by AMPK (show PRKAA1 Antibodies) at Ser304 is important for activation.
Lymphomas developing in a Pde4b-null background display significantly lower microvessel density in association with lower VEGF (show VEGFA Antibodies) levels and PI3K/AKT (show AKT1 Antibodies) activity.
Genetic variations in DISC1 influence formation of biochemical complex with PDE4 and GSK-3 and strengthen the possibility of synergistic interactions between these proteins.
PDE4B-deficient mice display impaired reversal learning in the Morris water maze compared to wild-type littermates.
Results identify PDE4B in the CaV1.2 (show CACNA1C Antibodies) complex as a critical regulator of ICa during beta-AR stimulation and suggest that distinct PDE4 (show PDE4A Antibodies) subtypes are important for normal regulation of calcium-induced calcium release in cardiomyocytes.
Findings demonstrate that PDE4D (show PDE4D Antibodies) and PDE4B have specialized functions in mouse embryonic fibroblasts with PDE4B controlling cAMP in a discrete subdomain near the plasma membrane.
induction is esssential for LPS (show TLR4 Antibodies)-activated tnf-alpha (show TNF Antibodies) responses
Data suggest that maternal glycemic response during pregnancy is associated with lower DNA methylation (show HELLS Antibodies) of 4 CpG sites within PDE4B gene in placenta (collected after term birth); 3 additional CpG sites are differentially methylated relative to maternal glucose response within TNFRSF1B (show TNFRSF1B Antibodies), LDLR (show LDLR Antibodies), and BLM (show BLM Antibodies) genes. (TNFRSF1B (show TNFRSF1B Antibodies) = TNF (show TNF Antibodies) receptor superfamily member-1B; LDLR (show LDLR Antibodies) = low density lipoprotein receptor (show LDLR Antibodies); BLM (show BLM Antibodies) = Bloom syndrome protein (show BLM Antibodies))
Smurf2 (show SMURF2 Antibodies), an E3 ubiquitin ligase (show MUL1 Antibodies), interacts with PDE4B and attenuates liver fibrosis through miR (show MLXIP Antibodies)-132 mediated CTGF (show CTGF Antibodies) inhibition.
HTT (show HTT Antibodies) forms a ternary protein complex with the scaffolding protein DISC1 (show DISC1 Antibodies) and cAMP-degrading phosphodiesterase 4 (PDE4 (show PDE4A Antibodies)) to regulate PDE4 (show PDE4A Antibodies) activity.
Low PDE4B expression is associated with sepsis.
PDE4B gene may be involved in the testicular abnormalities of men with DS and cryptorchidism.
This meta-analysis suggests that PDE4B SNPs are genetically associated with susceptibility to schizophrenia.
Our results suggest that PDE4B does not play an important role during the chemotactic response of human neutrophils
Our results support previously reported association of PDE4B variations with schizophrenia in other populations.
analysis of the mechanism underlying synergistic up-regulation of PDE4B2 via a cross-talk between PKA-Cbeta and p65 (show GORASP1 Antibodies)
ototopical post-inoculation administration of a PDE4 (show PDE4A Antibodies) inhibitor suppresses inflammation in this animal model, thus demonstrating the therapeutic potential of targeting PDE4 (show PDE4A Antibodies)
QTL-CI for IMF (show MDFI Antibodies) was reconfirmed with high significance, and its position was narrowed down to an interval of 4 cM (the region defined by markers PDE4B and SW1881)
This gene is a member of the type IV, cyclic AMP (cAMP)-specific, cyclic nucleotide phosphodiesterase (PDE) family. Cyclic nucleotides are important second messengers that regulate and mediate a number of cellular responses to extracellular signals, such as hormones, light, and neurotransmitters. The cyclic nucleotide phosphodiesterases (PDEs) regulate the cellular concentrations of cyclic nucleotides and thereby play a role in signal transduction. This gene encodes a protein that specifically hydrolyzes cAMP. Altered activity of this protein has been associated with schizophrenia and bipolar affective disorder. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.
phosphodiesterase 4B, cAMP-specific (phosphodiesterase E4 dunce homolog)
, phosphodiesterase 4B, cAMP-specific
, phosphodiesterase 4B
, 3',5'-cyclic AMP phosphodiesterase
, Phosphodiesterase 4B cAMP-specific (dunce
, Phosphodiesterase 4B, cAMP-specific (dunce
, cAMP-specific 3',5'-cyclic phosphodiesterase 4B
, cAMP-specific phosphodiesterase-4 B isoform
, dunce-like phosphodiesterase E4
, phosphodiesterase 4B, cAMP-specific (phosphodiesterase E4 dunce homolog, Drosophila)
, phosphodiesterase 4B, cAMP specific